Project on pharmacokinetics study of opioid drug product following insufflation of milled drug products

Ended Definitive Contract Awarded Last action

Contract number
HHSF223201510138C
Awardee
Awarding agency
Obligated
$1,293,840

Award facts

Contract value 100% obligated
$1,293,840.24 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Shawnee Mission, KS 66212, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00008 $0
Other Administrative Action 7 · Modification to extend the period of performance for an additional six (6) months. The period of performance will end 03/31/2019 instead of 09/30/2018. $0
Other Administrative Action 6 · Modification to correct the contractor supplier code $0
Other Administrative Action 5 · Modification request to correct the tax ID number $0
Change Order 4 · Modification request to incorporate additional manufacturing and testing to evaluate the effect of milling process on in vitro and in vivo endpoints as a… $66,887
Change Order 3 · Modification request to extend the period of performance until 09/30/2018 due to unforeseen delays. $304,149
Other Administrative Action 2 $0
Other Administrative Action 1 · Modification request to change the (COR) project on pharmacokinetics study of opioid drug product following insufflation of milled drug products $0
Original award $922,804

About this award

Written by GovTribe AI ·

This federal contract award was made by the Food and Drug Administration (FDA) to Altasciences Clinical Kansas Inc., a contract research organization specializing in early phase drug development services. The $1,293,840.24 firm fixed price definitive contract is for a project on the pharmacokinetics study of an opioid drug product following insufflation of milled drug products. The contract has an ultimate completion date of September 30, 2019 and was awarded on September 17, 2015. No set-aside was used for this award.

Altasciences Clinical Kansas Inc. has also received other federal contract awards, including a $1.8 million firm fixed price delivery order from the National Institute on Drug Abuse (NIDA) to conduct Phase 1 cocaine drug interaction trials from September 2023 through March 2025, and a $2.3 million firm fixed price definitive contract from the FDA for a dose-finding pilot study of kratom alkaloids through September 2024. These awards demonstrate Altasciences' experience in providing clinical pharmacology research services to support federal agencies' missions, particularly in the area of substance use disorder treatment development.

Quick answers

Who was awarded contract HHSF223201510138C?

HHSF223201510138C was awarded to Altasciences Clinical Kansas Inc. by Food and Drug Administration (Department of Health and Human Services) on September 17, 2015.

How much is contract HHSF223201510138C worth?

The government has obligated $1,293,840 on HHSF223201510138C.

Was contract HHSF223201510138C competed?

The extent of competition for HHSF223201510138C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login